COVID-19 associated severe respiratory syndrome. SARS-CoV-2
Conditions
Interventions
Intervention 1: Intervention group: patients with a probable diagnosis of COVID-19 will receive oral health care training by a nurse, including: tooth and tongue brush, cleaning dentures in people wi
Sponsors
Kashan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: possibility of involving to COVID-19 PaO2/FiO2 50% consciousness of patient and to be able to complete letter of satisfaction minimum 18 years old
Exclusion criteria
Exclusion criteria: Pregnancy patient Immunodeficiency such as patient with Severe combined immune deficiency and HIV Allergy to mouth rinse Immunosuppressant drug consumer such as transplantation recipient Dissatisfaction with participating in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Xerostomia. Timepoint: Daily during first day of hospitalization until 28 days. Method of measurement: percent (has/has not).;Duration of hospitalization. Timepoint: End of study. Method of measurement: Calculation.;Change of Taste sense. Timepoint: Daily during first day of hospitalization until 28days. Method of measurement: percent (has/has not).;New oral erythematous lesion. Timepoint: Daily during first day of hospitalization until 28 days. Method of measurement: percent (has/has not).;New oral ulcer. Timepoint: Daily during first day of hospitalization until 28 days. Method of measurement: percent (has/has not ). | — |
Secondary
| Measure | Time frame |
|---|---|
| Para clinical outcome (CURB65). Timepoint: The first day and the last day of discharge. Method of measurement: scale.;Para clinical outcome(White blood cell count). Timepoint: The first day and the last day of discharge. Method of measurement: cell number x 1000.;Para clinical outcome (blood potassium). Timepoint: The first day and the last day of discharge. Method of measurement: milligrams per deciliter.;Para clinical outcome (blood magnesium). Timepoint: The first day and the last day of discharge. Method of measurement: milligrams per deciliter.;Para clinical outcome (platelet count). Timepoint: The first day and the last day of discharge. Method of measurement: cell number x 1000.;Para clinical outcome (C Reactive protein). Timepoint: The first day and the last day of discharge. Method of measurement: milligrams per deciliter.;Para clinical outcome (Creatinine). Timepoint: The first day and the last day of discharge. Method of measurement: milligrams per deciliter.;Para clinical outcome(Respiratory rate per minute). Timepoint: The first day and the last day of discharge. Method of measurement: number of breath per minute.;Para clinical outcome(blood pressure). Timepoint: The first day and the last day of discharge. Method of measurement: millimeter of mercury.;Para clinical outcome(Body temperature). Timepoint: The first day and the last day of discharge. Method of measurement: centigrade.;Para clinical outcome (heart rate per minute). Timepoint: The first day and the last day of discharge. Method of measurement: beats per minute.;Para clinical outcome (Blood Urea nitrogen). Timepoint: The first day and the last day of discharge. Method of measurement: milligrams per deciliter.;Para clinical outcome (blood sodium ). Timepoint: The first day and the last day of discharge. Method of measurement: milligrams per deciliter.;Para clinical outcome (Blood glucose). Timepoint: The first day and the last day of discharge. Method of measurement: milligrams per deciliter. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElaheh GhasemzadehHosseini
Kashan University of Medical Sciences
Outcome results
None listed